Medical Devices are an essential element of healthcare by helping to diagnose, treat, monitor or alleviate medical conditions. They include a wide range of products, from simple everyday products like bandages to complex high-technologies like heart implants, and even medical software.
with 26.4 % of the Global Medical Device Market
Predicted Market Volume of €103.31 billion in Europe in 2025
In-Vitro Diagnostics (IVD), Cardiology,
Diagnostic Imaging
In the European Union (EU), Medical Devices are regulated under the Medical Device Regulation MDR (EU) 2017/745, a comprehensive and harmonized framework designed to ensure safety, performance, and clinical benefit for patients. These regulations are often seen as more adaptable to the diversity and fast-paced innovation of the Medical Device Industry than the U.S. FDA approval system.
The MDR (Article 2) defines a “Medical Device” as any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the following specific medical purposes:
The decisive part is the end of the definition: the principal intended action is not achieved by pharmacological, immunological or metabolic means, such means may assist the action, but must not carry it.
Before a Medical Devices reaches the EU market, it has to pass a conformity assessment to ensure that they comply with the applicable regulations. This includes testing the safety, performance and quality of the product according to the applicable standards. After successfully passing the assessment, the products receive the CE Mark, which confirms that they comply with the EU Directives.
In contrast to the centralized U.S. system, the European model relies on Notified Bodies, independent organizations that are designated to assess the conformity of products. This decentralized model allows for faster access to the market and encourages continuous improvement.
Safety does not end at market entry. It is monitored through a Vigilance System. Manufacturers, distributors and healthcare professionals are required to report adverse events and incidents related to Medical Devices. This information is analyzed to identify potential risks and take appropriate action to ensure patient safety.
For medical devices placed on the EU market, CE marking is mandatory. It confirms that the product meets the applicable EU requirements and has passed a conformity assessment.
The path to CE marking follows the risk class. Define the intended purpose and classification, build the technical documentation, demonstrate the general safety and performance requirements, set up quality management, involve the Notified Body from Class IIa upward, issue the declaration of conformity and place the CE mark.
A Notified Body is an independent, government-designated assessment organization in the EU. It reviews the technical documentation, audits the quality management system and issues the certificates for CE marking. It does not develop or.
Class I products are generally placed on the market by the manufacturer under their own responsibility. Exceptions that involve a Notified Body: measuring function (Im), sterile condition (Is), reusable surgical instruments (Ir). From Class IIa upward, a Notified Body is mandatory.
WQS supports the regulatory process for medical devices and in vitro diagnostic medical devices, from clinical evaluation through technical documentation to registration and covers the entire path to market access.
Collection and analysis of clinical data before and after market launch
Biocompatibility and biological safety of a medical device
Evaluation of a reusable medical device
Software lifecycle and requirements for AI-based functions
Quality, safety, and shelf life of materials and packaging
Functionality and ensuring IVD compliance with the IVDR
Risk assessment according to EN ISO 14971 to protect patient health
Graphic symbols for labeling, UDI (device and production identification), and EUDAMED registration
Distinguishing between a medical device and a medicinal product.
The distinction between the two lies in their mechanism of function. Pharmaceuticals act pharmacologically, immunologically or metabolically. Medical devices, on the other hand, act mechanically, physically or thermally. In borderline cases, such as substance-containing products, the principal action determines the entire approval process.
The range of medtech is wide: bandages, contact lenses, wheelchairs, infusion pumps, surgical instruments, pacemakers, imaging systems and software with a medical intended purpose. What connects them is not the technology, but the medical purpose.
The EU and the U.S. regulate the same goal through different systems. The central difference: the EU assesses in a decentralized way through several Notified Bodies, the U.S. centrally through the FDA.
| Aspect | EU (MDR 2017/745) | USA (FDA) |
|---|---|---|
| Assessment | Decentralized via Notified Bodies | Centralized via the FDA |
| Market access | CE marking | Clearance / approval |
| Route | Conformity assessment by class | 510(k), De Novo or PMA |
| Representation | CEU Authorized Representative for non-EU makers | U.S. Agent for non-U.S. makers |
Any manufacturer without a registered place of business in the EU needs an EU Authorized Representative to place devices on the EU market. It is a legal requirement, not an optional add-on. The representative is named in the technical documentation and on the label.
Where a product stands in regulatory terms decides effort, time and market access.
That question is settled at the start, not in the audit.
We check whether your product falls under the MDR and estimate your certification effort.
A medical device serves to diagnose, prevent, monitor, predict, treat or alleviate disease, injury or disability, or to investigate, replace or modify the anatomy or a physiological process, or to provide information through in-vitro examination of specimens. Its principal action is not achieved by pharmacological, immunological or metabolic means.
The EU system is decentralized and uses independent organizations called Notified Bodies to assess compliance and grants the CE mark. In contrast, the U.S. relies on a centralized FDA review process, via 510(k), De Novo or PMA depending on the class.
The CE Mark is a mandatory conformity mark that shows a Medical Device complies with EU safety, health and environmental protection standards.
Not always. Class I products (low risk) are generally placed on the market by the manufacturer, with exceptions for a measuring function, sterile condition or reusable surgical instruments. From Class IIa upward, a Notified Body is mandatory.
It reviews your technical documentation, audits your quality management system and issues the certificates for CE marking. WQS can manage the communication with your Notified Body.
Products range from simple items like bandages to complex technologies like heart implants – as long as they fulfill a medical purpose and meet the EU definition.
Yes. Without a registered place of business in the EU, you need an EU Authorized Representative to place devices on the EU market. It is a legal requirement.
A single number would be misleading. Cost depends on the risk class, product complexity, the state of the existing documentation and the Notified Body’s fees. Class I without a Notified Body is far less expensive than a Class III certification with a clinical investigation.
The mode of action decides. If it acts mainly pharmacologically, immunologically or metabolically, it leans toward a pharmaceutical. If it acts mechanically, physically or thermally, it is a medical device. In borderline cases the principal action counts.
From simple items like bandages to complex technologies like heart implants, as long as they serve a medical purpose and meet the EU definition.
This page provides regulatory information and does not constitute legal advice. Regulatory requirements vary by jurisdiction.
Copyright 2026 WQS Management Consultants GmbH – Alle Rechte vorbehalten
This website is for informational purposes only and provides partial excerpts from regulatory requirements. The complete texts of the regulations, harmonized standards, and guidelines, as currently in effect, are authoritative.
Note on images: Some of the illustrations and photos used on this website were created or edited using artificial intelligence.